Sakata Seed Corporation

TSE:1377 Stock Report

Market Cap: JP¥148.4b

Sakata Seed Valuation

Is 1377 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

5/6

Valuation Score 5/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 1377 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 1377 (¥3390) is trading below our estimate of fair value (¥5900.71)

Significantly Below Fair Value: 1377 is trading below fair value by more than 20%.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for 1377?

Key metric: As 1377 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 1377. This is calculated by dividing 1377's market cap by their current earnings.
What is 1377's PE Ratio?
PE Ratio9.7x
EarningsJP¥15.33b
Market CapJP¥148.43b

Price to Earnings Ratio vs Peers

How does 1377's PE Ratio compare to its peers?

The above table shows the PE ratio for 1377 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average25.9x
1379 Hokuto
15.3xn/aJP¥55.0b
2053 Chubu Shiryo
8.9xn/aJP¥39.4b
1376 Kaneko Seeds
14.6xn/aJP¥15.7b
1383 Berg EarthLtd
64.8xn/aJP¥4.9b
1377 Sakata Seed
9.7x-12.6%JP¥148.4b

Price-To-Earnings vs Peers: 1377 is good value based on its Price-To-Earnings Ratio (9.7x) compared to the peer average (25.9x).


Price to Earnings Ratio vs Industry

How does 1377's PE Ratio compare vs other companies in the JP Food Industry?

1 CompanyPrice / EarningsEstimated GrowthMarket Cap
2215 First Baking
1.9xn/aUS$26.23m
No more companies available in this PE range
1377 9.7xIndustry Avg. 15.0xNo. of Companies19PE01020304050+
1 CompanyEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: 1377 is good value based on its Price-To-Earnings Ratio (9.7x) compared to the JP Food industry average (15x).


Price to Earnings Ratio vs Fair Ratio

What is 1377's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

1377 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio9.7x
Fair PE Ratio12.3x

Price-To-Earnings vs Fair Ratio: 1377 is good value based on its Price-To-Earnings Ratio (9.7x) compared to the estimated Fair Price-To-Earnings Ratio (12.3x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 1377 forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentJP¥3,390.00
JP¥4,650.00
+37.2%
18.3%JP¥5,500.00JP¥3,800.00n/a2
Nov ’25JP¥3,505.00
JP¥4,650.00
+32.7%
18.3%JP¥5,500.00JP¥3,800.00n/a2
Oct ’25JP¥3,555.00
JP¥4,650.00
+30.8%
18.3%JP¥5,500.00JP¥3,800.00n/a2
Sep ’25JP¥3,440.00
JP¥4,650.00
+35.2%
18.3%JP¥5,500.00JP¥3,800.00n/a2
Aug ’25JP¥3,395.00
JP¥5,050.00
+48.7%
6.9%JP¥5,400.00JP¥4,700.00n/a2
Jul ’25JP¥3,445.00
JP¥5,050.00
+46.6%
6.9%JP¥5,400.00JP¥4,700.00n/a2
Jun ’25JP¥3,375.00
JP¥5,050.00
+49.6%
6.9%JP¥5,400.00JP¥4,700.00n/a2
May ’25JP¥3,670.00
JP¥5,450.00
+48.5%
0.9%JP¥5,500.00JP¥5,400.00n/a2
Oct ’24JP¥4,345.00
JP¥5,550.00
+27.7%
0.9%JP¥5,600.00JP¥5,500.00JP¥3,555.002
Sep ’24JP¥4,180.00
JP¥5,550.00
+32.8%
0.9%JP¥5,600.00JP¥5,500.00JP¥3,440.002
Mar ’24JP¥4,065.00
JP¥6,150.00
+51.3%
0.8%JP¥6,200.00JP¥6,100.00JP¥3,655.002
Feb ’24JP¥4,155.00
JP¥6,150.00
+48.0%
0.8%JP¥6,200.00JP¥6,100.00JP¥3,610.002

Analyst Forecast: Target price is more than 20% higher than the current share price, but there are not enough analysts covering the stock to determine statistical confidence in agreement.


Discover undervalued companies